Silber JL, Norman JM, Kanno T, Crossette EM, et al. A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in he Eur J Gastroenterol Hepatol 2025 Oct 23. doi: 10.1097/MEG.0000000000003098.
PMID: 41342324